Search

everythinglearnresearchcommunity

for

Search:↓

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Drug addicts often have scars, skin color changes, blocked veins, and bruising, with severe ulcers from barbiturate injections.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Minoxidil keeps most hair growth from first year and twice-daily use is better with few side effects.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.